116287-13-9 Usage
General Description
The chemical compound "(2R)-2-methyl-3-pyrrolidin-1-yl-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride" is a synthetic compound with a complex structure. It consists of a pyrrolidine ring attached to a phenylpropan-1-one group, and a trifluoromethyl group added to the phenyl ring. The presence of the hydrochloride salt form indicates that it is a salt of a protonated amine compound. (2R)-2-methyl-3-pyrrolidin-1-yl-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride may have potential applications in pharmacology and medicinal chemistry, given its complex structure and the presence of a chiral center, which can influence its interactions with biological systems. Further research is needed to understand the specific properties and potential uses of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 116287-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,2,8 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 116287-13:
(8*1)+(7*1)+(6*6)+(5*2)+(4*8)+(3*7)+(2*1)+(1*3)=119
119 % 10 = 9
So 116287-13-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H18F3NO.ClH/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18;/h4-7,11H,2-3,8-10H2,1H3;1H/t11-;/m1./s1
116287-13-9Relevant articles and documents
THERAPEUTIC DRUGS FOR POLLAKIURIA AND URINARY INCONTINENCE CONTAINING OPTICAL ACTIVE PROPIOPHENON AND ITS SALTS
-
, (2010/11/24)
Disclosed herein is a therapeutic agent for urinary frequency and incontinence, comprising an optically active propiophenone derivative or a pharmaceutically acceptable salt thereof as an effective ingredient. The therapeutic agent for urinary frequency and incontinence is an oral formulation comprising (-) - (R) -2-methyl-3- (1-pyrrolidinyl) - 4 '-trif luoromethyl-propiophenone hydrochloride as an effective ingredient. Unlike conventional therapeutic agents for urinary frequency and incontinence, the derivative has good therapeutic effects on urinary frequency and incontinence and minimal side effects because it acts on the central nervous system and inhibits micturition hyperreflexia. Thus, the present therapeutic agent can replace conventional therapeutic agents for urinary frequency and incontinence.
Derivatives of an aminoketone
-
, (2008/06/13)
A new class of aminoketone derivatives according to the formula: STR1 and certain propiophenone derivatives in particular, corresponding to the formula: STR2 having central muscle relaxant activity.
